Each year, an estimated 78 million people are infected with gonorrhoea, which can infect the genitals, rectum, and throat. Complications of gonorrhoea disproportionally affect women and can include pelvic inflammatory disease, ectopic pregnancy and infertility, as well as an increased risk of HIV.
Data from 77 countries show that antibiotic resistance is making gonorrhoea more difficult, and sometimes impossible, to treat. Some countries – particularly high-income ones, where surveillance is best – are finding cases of the infection that are untreatable by all known antibiotics. These cases may just be the tip of the iceberg, as gonorrhoea is more common in lower-income countries.
Currently, in most countries, ESCs are the only single antibiotic that remain effective for treating gonorrhoea. But resistance to cefixime – and more rarely to ceftriaxone – has now been reported in more than 50 countries. As a result, WHO issued updated global treatment recommendations in 2016 advising doctors to give 2 antibiotics: ceftriaxone and azithromycin.
For more information about Antibiotic-resistant gonorrhoea on the who.int website